ArticleAntibodies (Basel, Switzerland)2026

Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa.

Olga Strizhakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.